Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

Research Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) on Bullrun: market cap HKD 21.81B, P/E 51.7. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker2315.HK
ExchangeHK
CountryChina
SectorHealthcare
IndustryBiotechnology
CurrencyHKD
Market capHKD 21.81B
P/E51.7
Financial periodFY2025
RevenueCNY 1.38B
Revenue growth40.6%
Net incomeCNY 173.20M
Free cash flowCNY 282.43M
Gross margin75.8%

Valuation Snapshot

latest market cap is HKD 21.81B; P/E is 51.7.

Peer valuation comparison

Latest P/E is 51.75x versus a Healthcare sector median of 21.69x (138.6% above).

Latest P/E is 51.75x versus a China median of 16.26x (218.2% above).

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	CNY 1.38B	CNY 173.20M	CNY 282.43M	75.8%	0.43	CNY 1.56B	CNY 584.09M	CNY 2.17B
FY2024	CNY 980.45M	CNY 33.54M	CNY 174.12M	77.7%	0.08	CNY 381.18M	CNY 570.28M	CNY 834.06M
FY2023	CNY 716.91M	-CNY 382.95M	-CNY 203.26M	70.6%	-0.96	CNY 399.60M	CNY 544.11M	CNY 785.89M
FY2022	CNY 533.88M	-CNY 601.95M	-CNY 543.54M	73.4%	-1.58	CNY 603.07M	CNY 415.28M	CNY 1.15B

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	HKD 21.81B	51.7	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 HKD.

About Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., a biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People's Republic of China, the United States, and internationally. It operates through five segments: Gene-Editing; Pharmacological Efficacy; Model Animals; Antibody Development; and Other.

Related stock research

China stocks China Healthcare stocks A-Z stock index

Other Healthcare stocks

Hualan Biological Engineering INC (002007.SZ) Shanghai RAAS Blood Products Co Ltd (002252.SZ) Asymchem Laboratories (Tianjin) Co., Ltd. (002821.SZ) Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) CANbridge Pharmaceuticals Inc. (1228.HK) 3D Medicines Inc. (1244.HK) Ocumension Therapeutics (1477.HK) 3SBio Inc. (1530.HK) LongBio Pharma (Suzhou) Co., Ltd. (1779.HK) Innovent Biologics, Inc. (1801.HK) Viva Biotech Holdings (1873.HK) BioDlink International Company Limited (1875.HK)

Frequently asked questions

What is Biocytogen Pharmaceuticals (Beijing) Co., Ltd.'s market cap?

Biocytogen Pharmaceuticals (Beijing) Co., Ltd.'s market capitalization is HKD 21.81B.

What is Biocytogen Pharmaceuticals (Beijing) Co., Ltd.'s P/E ratio?

Biocytogen Pharmaceuticals (Beijing) Co., Ltd.'s price-to-earnings (P/E) ratio is 51.7.